Eledon Pharmaceuticals, Inc. — Director's Dealing 2016

Jun 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tokai Pharmaceuticals Inc (TKAI)
CIK: 0001404281
Period of Report: 2016-06-15

Reporting Person: BARBERICH TIMOTHY J (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-15	Stock Option (right to buy)	$6.29	A	12000.00	Acquired	2026-06-14	Common Stock (12000.00)	Direct

Footnotes

F1: This option vests with respect to 100% of the shares underlying the option on June 15, 2017 subject to his continued service on Tokai's Board of Directors.